908 Devices Inc.

MASS Healthcare Medical Devices

In the quarter to June 2026, revenue grew 23.3%, EPS grew 13.5% and free cash flow grew 151.0%, each against the same quarter a year earlier.

11.33 0.56 −4.71%
Market cap
$491.5M
P/E
0.0×
Fwd P/E
−13.3×
Dividend yield
—
F-score
5/9
Altman Z
1.10
Beneish M
−2.52
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — 6 3 3 3 4 5
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.38
Altman Z-Score
— — — 5.21 9.81 2.68 5.06 (1.43) 1.10
P/S ratio
— 8.30 8.30 14.70 17.14 4.93 6.37 1.57 3.35
Altman Z″-Score (non-manufacturers)
— — (4.58) 7.89 9.03 6.38 5.37 (1.50) 1.84
P/FCF ratio
— 0.00 0.00 95.91 0.00 0.00 0.00 0.00 0.00
Beneish M-Score
— — 1.04 (2.73) (1.52) (1.94) (2.59) (2.67) (2.52)
P/Operating CF
— 29.89 29.89 169.53 (78.45) (45.18) (165.71) (33.42) 142.89
P/B ratio
— 0.00 0.00 2.84 3.37 1.21 1.93 0.65 1.31
Price to Tangible BV
— 0.00 0.00 2.84 3.37 1.34 2.17 0.99 1.76
EV/Sales
— 8.38 8.38 9.33 12.20 1.24 3.78 0.45 1.62
EV/EBITDA
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
— (26.87) (26.87) 60.75 (17.70) (2.78) (7.57) (0.71) (3.84)
EV/FCF
— (25.75) (25.75) 60.88 (17.26) (2.53) (7.00) (0.70) (3.69)
Quick Ratio
— 2.82 3.80 15.33 16.21 10.32 6.86 3.09 3.65
Current Ratio
— 3.61 4.72 15.78 17.05 11.22 7.71 4.10 4.24
Net Debt/EBITDA
— (1.96) 0.18 28.97 9.89 5.14 3.58 5.73 3.17
Debt/Assets
0.00% 64.63% 42.08% 8.29% 5.75% 6.18% 0.00% 0.00% 0.00%
Debt/Equity
— 6.16 (0.25) 0.11 0.07 0.08 0.00 0.00 0.00
Asset Turnover
— 1.59 0.55 0.25 0.19 0.19 0.23 0.26 0.32
Operating CF/Net income
— 1.17 0.82 (0.32) 1.31 0.62 0.69 0.42 (1.22)
Capex/Depreciation
— 0.00 (0.44) (0.01) (0.80) (1.27) (0.98) (0.01) (0.25)
Interest Coverage
— (10.33) (7.94) (5.96) (45.41) (274.28) (212.73) — —
ROE
— 13.43% 23.79% (34.03%) (12.54%) (16.57%) (20.44%) (51.56%) 15.09%
ROA
— (54.87%) (41.22%) (11.93%) (10.08%) (13.33%) (16.34%) (39.84%) 11.15%
ROIC
— 0.00% 0.00% 0.00% (249.38%) (128.74%) (134.91%) (78.54%) (80.18%)
Return on Tangible Assets
— (33.89%) (56.52%) (8.02%) (9.25%) (16.82%) (23.55%) (90.82%) 16.99%
Average Days of Receivables
— 104.86 103.15 92.63 141.61 78.16 65.32 67.67 73.57
Research and Development Expense of Revenue
— 43.20% 50.04% 30.62% 30.96% 37.41% 43.61% 31.39% 27.72%
Selling, General and Administrative Expense of Revenue
— 42.19% 62.84% 46.49% 76.38% 93.65% 91.72% 82.65% 68.56%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.08 0.09 0.24 0.19
Share Based Compensation of Revenue
— 0.00% 1.49% 1.95% 5.93% 15.38% 19.48% 24.64% 17.52%
Graham Net Nets
— 0.14 0.14 0.33 0.29 0.71 0.43 0.78 0.52
Graham Number
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.10
Earnings Yield
— (1.10%) (1.10%) (3.51%) (3.09%) (14.58%) (11.39%) (95.45%) 10.67%
Free Cash Flow Yield
— (3.92%) (3.92%) 1.04% (4.12%) (9.94%) (8.48%) (41.15%) (13.08%)
Revenue per Share
— 0.84 3.60 4.90 1.51 1.49 1.56 1.40 1.57
Operating CF per Share
— (0.34) (2.21) 0.75 (1.04) (0.66) (0.78) (0.89) (0.66)
Capex per Share
— 0.00 (0.08) 0.00 (0.03) (0.06) (0.06) (0.02) (0.03)
Free Cash Flow per Share
— (0.34) (2.28) 0.75 (1.07) (0.73) (0.84) (0.91) (0.69)
Cash per Share
— 0.27 3.59 29.03 8.01 5.98 4.52 2.02 3.15
Shareholders Equity per Share
— 0.11 (12.66) 25.35 7.68 6.05 5.13 3.36 4.00
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— 0.11 (12.66) 25.35 7.68 6.05 5.13 3.36 4.00
Free Cash Flow
— (8.90) (11.40) 4.12 (29.82) (22.97) (27.10) (30.85) (24.64)
Working Capital
— 12.44 22.53 160.13 238.06 196.40 151.24 77.91 110.50
Capital Expenditures
— (0.73) (0.39) (0.01) (0.74) (2.04) (2.04) (0.60) (0.95)
Net Current Asset Value
— (7.63) (72.25) 131.18 206.59 163.64 136.30 58.17 98.19
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
— 0.00 0.02 0.00 0.02 0.04 0.04 0.01 0.02
Price to Operating Income
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
— 0.09 0.68 0.98 0.58 0.52 0.62 28.44 0.90
Cash ROIC
— (31.87%) 38.75% 1.32% (6.57%) (5.83%) (8.71%) (16.81%) (9.60%)
Accounts Receivable Turnover
— 3.86 3.15 4.52 3.64 3.55 5.28 5.35 5.57
Accounts Payable Turnover
— 15.81 16.09 15.14 15.98 15.05 19.25 18.17 18.80
Inventory Turnover
— 2.21 2.24 2.44 3.04 2.04 1.81 1.80 2.33
Average Days of Payables
— 24.37 21.43 30.61 26.38 24.48 17.45 21.48 20.84
Days of Inventory on Hand
— 133.10 194.48 139.28 152.33 219.27 218.91 170.93 170.71
Average Receivables
— 5.71 5.71 5.95 11.60 13.20 9.51 8.92 10.09
Average Payables
— 0.61 0.61 0.79 1.19 1.38 1.29 1.28 1.48
Average Inventory
— 4.38 4.38 4.90 6.24 10.22 13.73 12.91 11.94
Average Assets
— 13.87 32.71 108.24 219.87 251.75 222.78 181.23 174.77
Average Common Equity
— (56.67) (56.67) 37.94 176.82 202.60 178.05 140.04 129.15

Fold the line items

Columns are period end dates